November 1, 2012
The '90s was an enthusiastic time. With the fall of communism in 1989 and the emergence of the free economy, the international pharmaceutical industry arrived in the Czech Republic to find a highly receptive market.
|
October 1, 2012
In the global theater of business and politics, Turkey increasingly leverages its location as an ideal vantage point where actors can seamlessly move between all things West and East.
|
August 1, 2012
Over ten years ago, the economic concept of the 'BRIC' countries—Brazil, Russia, India and China—was formed, and it's pretty much all we've heard about ever since. Yet earlier this year, the very same man who coined the term—Jim O'Neill, chief economist at Goldman Sachs—declared that by 2020 Mexico would be the seventh largest economy in the world, surpassing both India and Russia. Mexico belongs to one of four recently defined 'growth markets' alongside Indonesia, South Korea and Turkey. That certainly shakes things up a little for both outside observers and active local stakeholders in the economy.
|
July 1, 2012
Indochina's biggest pharmaceutical market (US$ 4 billion, 66 million population, <5 percent of GDP spent on healthcare) has quickly matured over the past years due to the implementation of heavy cost containment measures meant to make healthcare more accessible to the patient. These measures have driven the market from double-digit growth to almost flat growth within the course of two years.
|
May 1, 2013
While Austria experienced significant political and economic shake-up throughout the 20th century, the country has remained a key strategic market for the pharmaceutical industry thanks to its steady economic development and inclination for innovation.
|
April 1, 2013
Belgium is a hub for clinical trials, a leader in the biopharmaceutical industry, and a center for pharmaceutical production and distribution.
|
March 1, 2013
China's pharmaceutical industry is making record gains. Four years ago, China was the world's fifth largest market. Now, it has bypassed France and Germany to become the third largest. By 2015, China will pass Japan to rival only the United States for number one.
|
February 1, 2013
In some ways the Australian medicines industry is going through the same restructuring and challenges as the industry is globally: the country is dealing with patent cliffs, companies are cutting back staff, an ageing population forces the government to rethink healthcare expenditures, and big originator companies are reforming.
|
January 1, 2013
Most executives across the pharmaceutical industry agree—Singapore does not represent any question marks in the future. Furthermore, Singapore's location is ideal for reaching markets east, west, north and south, which form the powerhouse that is Asia-Pacific.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
